Not available outside of the UK & Ireland.
Biochem/physiol Actions
Potent, orally active, non-peptide B2 bradykinin receptor antagonist.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
5 mg in glass bottle
25 mg in poly bottle
This product has met the following criteria to qualify for the following awards: